Given that 15–20% of emphysema and lung cancers worldwide are TS-related [45], NB activation of the IGF2-IGF-1R/IR signaling pathway may help us understand the pathogenesis underlying the development of these two deadly diseases in smokers. The gene discussed is IGF2; the disease is pulmonary emphysema.